MARKET

NEO

NEO

Neogenomics Inc
NASDAQ
8.00
+0.31
+4.03%
After Hours: 7.75 -0.25 -3.13% 17:22 05/07 EDT
OPEN
7.93
PREV CLOSE
7.69
HIGH
8.03
LOW
7.66
VOLUME
1.56M
TURNOVER
--
52 WEEK HIGH
19.12
52 WEEK LOW
6.08
MARKET CAP
1.03B
P/E (TTM)
-13.0954
1D
5D
1M
3M
1Y
5Y
1D
Assessing NeoGenomics: Insights From 9 Financial Analysts
Benzinga · 1d ago
NeoGenomics Is Maintained at Overweight by Piper Sandler
Dow Jones · 1d ago
NeoGenomics Price Target Cut to $12.00/Share From $18.00 by Piper Sandler
Dow Jones · 1d ago
Piper Sandler Maintains Overweight on NeoGenomics, Lowers Price Target to $12
Benzinga · 1d ago
It's Not Too Late to Jump on These Under-the-Radar Momentum Plays
NASDAQ · 1d ago
NeoGenomics price target lowered to $12 from $18 at Piper Sandler
TipRanks · 1d ago
Piper Sandler Keeps Their Buy Rating on NeoGenomics (NEO)
TipRanks · 1d ago
NEOGENOMICS INC <NEO.O>: PIPER SANDLER CUTS TARGET PRICE TO $12 FROM $18
Reuters · 2d ago
More
About NEO
More
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.
Recently
Symbol
Price
%Change

Webull offers NeoGenomics, Inc. stock information, including NASDAQ: NEO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NEO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NEO stock methods without spending real money on the virtual paper trading platform.